Skip to main content
. 2013 Jun 3;31(20):2607–2618. doi: 10.1200/JCO.2012.48.2596

Table 4.

Association of Endometrial Cancer Risk Factors With Type I and Type II Tumors

Risk Factor No. of Controls Cases
P heterogeneity
Type I*
Type II
No. of Cases OR 95% CI No. of Cases OR 95% CI
Mean age at diagnosis, years 12,853 62.7 854 64.8 < .0001
Body mass index, kg/m2
    < 25 18,400 4,602 1.00 330 1.00
    25 to < 30 10,986 3,718 1.45 1.37 to 1.53 253 1.16 0.98 to 1.38
    30 to < 35 4,078 2,294 2.52 2.35 to 2.69 159 1.73 1.40 to 2.12
    35 to < 40 1,255 1,247 4.45 4.05 to 4.89 65 2.15 1.60 to 2.88
    ≥ 40 593 992 7.14 6.33 to 8.06 47 3.11 2.19 to 4.44
    P trend < .0001 < .0001 < .0001
Body mass index, per 2 kg/m2 35,312 12,853 1.20 1.19 to 1.21 854 1.12 1.09 to 1.14 < .0001
Age at menarche, years
    < 11 1,633 844 1.00 68 1.00
    11-12 7,332 2,832 0.89 0.80 to 0.99 220 0.67 0.50 to 0.90
    13-14 21,563 7,528 0.85 0.77 to 0.94 466 0.62 0.47 to 0.82
    ≥ 15 4,784 1,649 0.71 0.63 to 0.80 100 0.50 0.35 to 0.70
    P trend < .0001 .0002 .11
Parity
    0 4,593 2,451 1.00 150 1.00
    1 4,528 1,999 0.74 0.68 to 0.81 121 0.84 0.65 to 1.09
    2 10,147 3,728 0.67 0.63 to 0.72 250 0.67 0.54 to 0.83
    3 12,119 3,686 0.56 0.52 to 0.60 231 0.56 0.45 to 0.70
    ≥ 4 3925 989 0.40 0.36 to 0.44 102 0.54 0.41 to 0.72
    P trend < .0001 < .0001 .31
Oral contraceptive use
    Never 20,785 8,011 1.00 497 1.00
    Ever 14,527 4,842 0.73 0.69 to 0.77 357 0.74 0.62 to 0.89 .17
Cigarette smoking§
    Never 18,815 7,692 1.00 532 1.00
    Former 10,900 3,648 0.87 0.82 to 0.91 227 0.70 0.59 to 0.83 .11
    Current 5,152 1,126 0.64 0.60 to 0.70 80 0.60 0.46 to 0.77 .79
Pack-years of smoking
    Never 13,693 5,646 1.00 367 1.00
    < 20 5,383 1,639 0.86 0.80 to 0.92 106 0.69 0.55 to 0.87
    ≥ 20 3,594 1,109 0.71 0.65 to 0.77 69 0.68 0.52 to 0.90
    P trend < .0001 .0006 .44
Diabetes
    No 26,575 8,520 1.00 472 1.00
    Yes 2,077 1,402 1.27 1.17 to 1.38 104 1.53 1.19 to 1.95 .14

Abbreviation: OR, odds ratio.

*

Type I included endometrioid adenocarcinoma, adenocarcinoma not otherwise specified, and adenocarcinoma with squamous differentiation.

Type II included serous and mixed cell adenocarcinoma.

Stratified by age, study and race/ethnicity and mutually adjusted for BMI, age at menarche, parity, oral contraceptive use, menopausal status, menopausal hormone use, and smoking status.

§

Based on 23 studies with smoking data.

Based on 18 studies with pack-years of smoking data.

Based on 19 studies with diabetes data.